The Efficacy and Safety of Anti-inflammation Treatment (Hirudoid Introduction Followed by Yellow Light Therapy) Combined With Tofacitinib and Doxycycline in Chinese Adult Patients With Mild to Moderate Erythematous Telangiectatic Rosacea

NCT07343635 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Erythematotelangiectatic Rosacea

Interventions

DRUG: Doxycycline
DRUG: Hydroxychloroquine
DRUG: Tofacitinib
DEVICE: Anti-inflammatory Treatment (Hirudoid Introduction Followed by Yellow Light Therapy)

Sponsor

The Fourth Affiliated Hospital of Zhejiang University School of Medicine